Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise.

Stenlöf, K; T Cefalu, W; Kim, K-A; Alba, M; Usiskin, K; Tong, C; Canovatchel, W; Meininger, G

doi:10.1111/dom.12054

Public

Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise.

Shared by NobleBlocks on Apr 1, 2013 • 12:00 AM UTC

Authors:

K Stenlöf

W T Cefalu

K-A Kim

Abstract

AIMS: Canagliflozin is a sodium glucose co-transporter 2 inhibitor in development for type 2 diabetes mellitus (T2DM). The efficacy and safety of canagliflozin were evaluated in subjects with T2DM inadequately controlled with diet and exercise. METHODS: In this 26-week, randomized, double-blind, pla...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!